Services & Applications

Thymed’s Visualizing Immunity™ platform creates value by providing critical information at multiple stages of the drug, vaccine and therapeutic development process.

Arrive at your GO/NO-GO decision quickly and reliably – save time, save money.

Epitope Discovery
Using iTOPIA™ (T-cells) and Peptide Microarrays (B-cells), Thymed can identify novel epitopes and immunogenic regions on individual antigens.

Epitope Validation
Thymed utilizes T-cell based assays or ELISA/EIA and peptide microarrays to screen relevant patient cells or body fluid to validate novel and existing epitopes.

Immunotoxicology
Does your novel therapeutic or new drug entity impact on immune cell survival / activation / proliferation ex vivo?

Immunogenicity
Is your novel therapeutic or new drug entity immunogenic? Does it activate immune cells?

Immune Status
What is the immune status of the individual study participant?

Immune Monitoring
Monitor the patient for effects on the immune system in response to developmental therapy.

Biomarkers
Characterize biomarkers in relation to disease and immune system status and in response to the novel therapeutic or new drug entity.

Consultation
Thymed is happy to provide consultation on assay appropriateness, assay interpretation and any other immunological aspects of your proposed or ongoing development.

© 2007 Thymed GmbH, Wendelsheim, Germany. All rights reserved • Imprint